Hyperlipidaemia of diabetes.

Area of Science:

• Endocrinology and Metabolism
• Lipid Metabolism
• Diabetes Research

Background:

• Diabetes mellitus significantly impacts plasma lipoprotein and lipid concentrations.
• Lipoprotein changes in diabetes are subgroup-specific and influenced by glycaemic control.
• Controversies persist regarding plasma LDL cholesterol levels in diabetic individuals.

Purpose of the Study:

• To review current research on lipoprotein and lipid alterations in diabetes.
• To clarify the role of insulin in hepatic VLDL secretion and gut lipogenic substrate production.
• To investigate the contribution of lipoprotein remnants to diabetic dyslipidaemia.

Main Methods:

• Review of recent research findings on diabetes and lipid metabolism.
• Analysis of studies on insulin's effect on VLDL secretion.
• Examination of metabolic studies, including animal models, on lipoprotein remnants.
• Evaluation of research on apoprotein and lipid content in lipoprotein metabolism.

Main Results:

• Detailed patterns of lipoprotein and lipid changes depend on factors like glycaemic control.
• Insulin's direct stimulation of hepatic VLDL secretion and its regulation of gut substrate production require further investigation.
• Evidence suggests increased lipoprotein remnants may contribute to diabetic dyslipidaemia, with origin and clearance defects needing determination.
• Changes in apoprotein and lipid content appear more critical than receptor activity for atherogenic lipoprotein clearance in diabetes.

Conclusions:

• Understanding insulin's coordination of metabolic activities is key to resolving diabetic hyperlipidaemia.
• Further research is needed to determine the origin and clearance mechanisms of lipoprotein remnants in diabetes.
• Factors influencing apoprotein and lipid content are crucial for clearing atherogenic lipoproteins like LDL in diabetic subjects.